Neuropediatrics 2021; 52(S 01): S1-S53
DOI: 10.1055/s-0041-1739611
Poster Abstracts

What Magnitude of Reduction Is a “Clinically Meaningful” Change in Seizure Frequency? Analysis of Long-Term Fenfluramine Phase 3 Dravet Syndrome Data

T. Polster
1   Department of Epileptology, Bielefeld University, Krankenhaus Mara, Bielefeld, Germany
,
A. Gammaitoni
2   Zogenix, Inc., Emeryville, California, United States
,
J. Sullivan
3   University of California San Francisco, California, United States
,
S. Perry
4   Cook Children's Medical Center, Fort Warth, Texas, United States
,
E. Wirrell
5   Department of Child Neurology, Mayo Clinic, Rochester, Minnesota, United States
,
G. Farfel
2   Zogenix, Inc., Emeryville, California, United States
,
B. Galer
2   Zogenix, Inc., Emeryville, California, United States
,
R. Nabbout
6   Hôpital Universitaire Necker- Enfants Malades, Service de Neurologie Pédiatrique Centre de Référence Épilepsies Rares (CreER), Paris, France
› Author Affiliations
 
 

    Background/Purpose: A 50% reduction in monthly convulsive seizure frequency (MCSF) is traditionally accepted as clinically meaningful, although this threshold is largely empirically derived. Here, we used a robust, anchor-based method in a long-term open-label extension (OLE) study of fenfluramine for the treatment of Dravet syndrome to quantify the degree of MCSF reduction associated with various parents/caregiver/investigator Clinical Global Impression of Improvement (CGI-I) ratings.

    Methods: MCSF and CGI-I data were derived from an OLE interim analysis (N = 330; October 19, 2020). Correlations between MCSF and CGI-I were analyzed by Spearman's rho. Receiver operating characteristic (ROC) analysis compared change in MCSF with binary versions of investigator and caregiver CGI-I Likert scale ratings. The cut point for a clinically meaningful change, defined by ratings of “much improved” or “very much improved” on CGI-I, was defined as the change in MCSF where sensitivity was approximately equal to specificity.

    Results: Caregiver or investigator CGI data at last visit were available from 299 and 313 patients, respectively. MCSF reduction was positively correlated with improvement in caregiver/investigator CGI-I scores (Spearman's rho, 0.530–0.545; p < 0.0001). ROC analysis identified a 60.5% reduction in MCSF as the clinically meaningful cutoff for subjects rated as “Much Improved” or “Very Much Improved.” Additionally, a 72% reduction in MCSF was associated with caregiver/investigator CGI-I ratings of “Very Much Improved.”

    Conclusion: This analysis of the association between percent reduction in MCSF and CGI-I suggests that a sustained 60.5% reduction from baseline in convulsive seizure frequency can be considered a clinically meaningful response.

    The data were first presented at IEC 2021 Virtual Congress.


    #

    No conflict of interest has been declared by the author(s).

    Publication History

    Article published online:
    28 October 2021

    © 2021. Thieme. All rights reserved.

    Georg Thieme Verlag KG
    Rüdigerstraße 14, 70469 Stuttgart, Germany